AI assistant
Calliditas Therapeutics Major Shareholding Notification 2022
3020_iss_2022-07-05_7ca3f417-4339-4baa-9997-4dc34e6810e9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Calliditas Therapeutics AB
Holder
Stiftelsen Industrifronden
Instrument
| Instrument | Ordinary shares SE0010441584 |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Corporate action | |
| Date | 01/07/2022 |
| Limit for number of shares | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 5,772,995 |
| Directly held voting rights | 5,772,995 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 9.76716 % |
| Directly held voting rights | 10.73267 % |
| Indirectly held voting rights | 0 % |
| Resulting distribution of total |
holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 10.73267 % | 5,772,995 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 10.73267 % | 5,772,995 |
| Group total holdings |
||
| Voting rights 5,772,995 |
Percentage of voting rights 10.73267 Notes (other relevant informations according to law)
Changes due to: Issuance of C-shares (1/10 voting)
Published
05/07/2022 16:37
Contact
Name Patrik Sobocki Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25